MedTrace Logo

Ketogenic Diet in PCOS With Obesity and Insulin Resistance

NCT04801173 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-01-27

No results posted yet for this study

Summary

The purpose of the VLCKD randomized clinical trial is to demonstrate the superiority of very low calorie ketogenic diet with respect to the standard low calorie diet in reducing body weight and insulin resistance in obese and insulin resistant patients with Polycystic Ovary Syndrome

Conditions

Interventions

COMBINATION_PRODUCT

Very low calorie ketogenic diet

Dietary intervention with a very low calorie ketogenic diet, using commercial products of the Pronokal PnK® method

BEHAVIORAL

Low calorie standard diet

Low calorie standard diet with no specified dietary supplement addition

Sponsors & Collaborators

  • Pronokal group

    collaborator UNKNOWN

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-02
Primary Completion
2021-12-06
Completion
2021-12-06

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04801173 on ClinicalTrials.gov